The off-target lorlatinib-resistant neuroblastoma cell line (CLB-Ga-LR1000) also experienced the upregulation of CALR after incubation with lorlatinib (1.0 μM) for 20 h (Figure 1C, right panel). This evidence concerns the gene CALR and neuroblastoma.